Compounded and counterfeit semaglutide poses a serious risk to patients
It’s no secret that public interest in glucagon-like peptide 1 (GLP-1) agonists has been growing rapidly, and the search popularity of semaglutide (Ozempic; Novo Nordisk) grew exponentially between March 2018 …